About Global Coalition for Adaptive Research
Global Coalition for Adaptive Research is a Healthcare company based in Lexington (United States) founded in 2017. Nonprofit organization sponsors clinical trials for rare diseases worldwide. It operates on a B2B and Non-profit Collaboration model. The company has 21 employees. Global Coalition for Adaptive Research offers products and services including GBM AGILE, REMAP-CAP, and Ovarian CanceRx. Its focus areas include Oncology Research, Cancer Trials, Glioblastoma Studies and Medical Research. Its legal entity is GLOBAL COALITION FOR ADAPTIVE RESEARCH (GCAR). Its competitors include Vial, Javara Research and Alcanza Clinical Research; 2 of its 3 listed competitors have raised funding.
Company details
Global Coalition for Adaptive Research is a nonprofit that develops and sponsors master protocols and adaptive platform trials to accelerate treatment discovery for rare and deadly diseases. It collaborates with investigators and partners to design innovative trials for conditions like glioblastoma and COVID-19. Based in Larkspur, California, USA, GCAR focuses on efficient, seamless research to improve patient outcomes through international trial sites and scientific expertise.
- Headquarters Lexington, United States
- Employees 21
- SectorsHealthcare
- Phone•••• ••••
- Website gcaresearch.org
- Social LinkedIn X Facebook Instagram
- Legal Name Global Coalition For Adaptive Research (Gcar)
- Employee Count21
Products & Services of Global Coalition for Adaptive Research
Global Coalition for Adaptive Research offers a comprehensive portfolio of products and services, including GBM AGILE, REMAP-CAP, and Ovarian CanceRx.
Adaptive trial evaluating treatments for glioblastoma.
Platform trial for COVID-19 treatments and responses.
Trial focused on ovarian cancer therapies development.
People of Global Coalition for Adaptive Research
6 people are tracked at Global Coalition for Adaptive Research (5 in leadership, 1 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
Rob Murray | Chief Business And Strategy Officer | Leadership |
Meredith Buxton | CEO & President | Leadership |
Rachael Coleman | CFO And COO | Leadership |
Matthew Viva | Director, Legal | Leadership |
Rachel Rosenstein-Sisson | Senior Director, Communications / Learning & Development | Leadership |
Jennifer Smith | Senior Accounting Associate | Team |
Complete people profiles for Global Coalition for Adaptive Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Global Coalition for Adaptive Research
Global Coalition for Adaptive Research has 3 listed competitors in our database, 2 of them funded. They include Vial, Javara Research and Alcanza Clinical Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vial.com | 2020 | San Francisco, United States | $67M | 65 | Healthcare data capture, clinical trials, and CRO services are provided. | |
| javararesearch.com | 2018 | Winston-salem, United States | $44.98M | Clinical trials for pharmaceuticals are conducted across therapeutic areas. | ||
| alcanzaclinical.com | 2021 | Methuen, United States | Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation |
Detailed competitors of Global Coalition for Adaptive Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Global Coalition for Adaptive Research (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Global Coalition For Adaptive Research
Complete news archive for Global Coalition for Adaptive Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Global Coalition for Adaptive Research
Global Coalition for Adaptive Research was founded in 2017.
Global Coalition for Adaptive Research is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Global Coalition for Adaptive Research has 21 employees.
Global Coalition for Adaptive Research is a nonprofit that develops and sponsors master protocols and adaptive platform trials to accelerate treatment discovery for rare and deadly diseases. It collaborates with investigators and partners to design innovative trials for conditions like glioblastoma and COVID-19. Based in Larkspur, California, USA, GCAR focuses on efficient, seamless research to improve patient outcomes through international trial sites and scientific expertise.
Global Coalition for Adaptive Research's top competitors include Javara Research, Vial and Alcanza Clinical Research.
Global Coalition for Adaptive Research offers GBM AGILE, REMAP-CAP, and Ovarian CanceRx.
Global Coalition for Adaptive Research operates through Global Coalition For Adaptive Research (Gcar).